TrialBlood2016

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.

Marco Mielcarek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.